Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
about
Mycobacterium tuberculosis: success through dormancySuccinylome analysis reveals the involvement of lysine succinylation in metabolism in pathogenic Mycobacterium tuberculosisTriazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expressionMycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochloriteThe multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediatesIn vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in miceExpansion of the mycobacterial "PUPylome"Lipoic acid metabolism in microbial pathogens.Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.The Sculpting of the Mycobacterium tuberculosis Genome by Host Cell-Derived PressuresSystems-based approaches to probing metabolic variation within the Mycobacterium tuberculosis complex.Mycobacterial survival strategies in the phagosome: defence against host stresses.Mycobacterium tuberculosis metabolismThe Mycobacterium marinum mel2 locus displays similarity to bacterial bioluminescence systems and plays a role in defense against reactive oxygen and nitrogen species.The tuberculosis drug discovery and development pipeline and emerging drug targets.A Mycobacterium marinum mel2 mutant is defective for growth in macrophages that produce reactive oxygen and reactive nitrogen speciesE1 of α-ketoglutarate dehydrogenase defends Mycobacterium tuberculosis against glutamate anaplerosis and nitroxidative stress.Phthiocerol dimycocerosate transport is required for resisting interferon-gamma-independent immunity.Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosisNovel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.Recent advances in antituberculous drug development and novel drug targets.Challenges and opportunities in developing novel drugs for TB.Effect of carbon monoxide on Mycobacterium tuberculosis pathogenesis.Tuberculosis drug discovery and emerging targets.Selective killing of nonreplicating mycobacteria.Small Molecules That Sabotage Bacterial Virulence.Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages.Development of new antituberculous agents based on new drug targets and structure-activity relationship.MadR1, a Mycobacterium tuberculosis cell cycle stress response protein that is a member of a widely conserved protein class of prokaryotic, eukaryotic and archeal originLack of mycothiol and ergothioneine induces different protective mechanisms in Mycobacterium smegmatisCentral carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier.Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes.The response of mycobacterium tuberculosis to reactive oxygen and nitrogen speciesIdentification and characterization of the genetic changes responsible for the characteristic smooth-to-rough morphotype alterations of clinically persistent Mycobacterium abscessus.Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?Genetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrest.CitE Enzymes Are Essential for to Establish Infection in Macrophages and Guinea Pigs
P2860
Q26852023-D0324B84-47B9-4E44-A45B-94476E735CF7Q27311660-87A6EF14-EB0F-4122-885E-5043F8BF9279Q27658975-0FABCC60-4720-471D-BAF8-6C12DA47CCDCQ28477282-AA4B8E3B-FA30-4687-BF99-EE2F070E4370Q28486777-A607E590-DE93-4EFF-ADF5-3C5EA89096D7Q28487623-0D3436D0-A7A3-404A-B956-6CECC8F91987Q28909142-61D76F7C-18C9-4EF5-A1B7-FAD1BBBED1B9Q33757745-616DAB0B-B63D-421A-94B6-6FB9B0D94A6AQ33909117-8589B509-6367-4E36-9ED4-E5812BC59C1CQ34423996-126CB97E-102A-4A48-9298-87B61E47BEADQ34888988-81FB9F50-81D0-48D5-900D-EC1686F76F0CQ35010150-C1A9A7D4-E831-4A2E-8D9E-8BBEEB0B646AQ35205535-F5DB5EC2-FBF5-43A5-A160-A4C4DDD58A64Q35245286-DB46CCAA-3AF6-4FB0-94ED-5ECC82E55174Q35628763-B3B78148-1ADB-4EA4-9EF6-D8801D7CA700Q35664209-7CF69B80-857B-4260-B28A-0CDCCB6F7835Q35689078-85D6B7A6-AD4A-490F-81C5-50139D0B770AQ36238449-716B54DC-0A76-411A-AE3A-7846FD3D4826Q36914816-A931B9A6-730C-4A06-9181-B28E720A36C6Q36933343-E53ADE2A-B6A6-4FDE-8BB8-5DB1F11C20F6Q37101494-3CFCCB13-A593-4E61-85C2-E8E672835CD6Q37754884-2C96AFC6-94F5-495A-8E0F-3D376BCAF104Q37924294-7C4E9F58-4D68-40A3-A4AF-10CDFEA22F7EQ38067824-357955B4-0653-4765-9DB7-B49EC9BBF9D5Q38219605-991D9965-DAE8-4B34-951D-A6C769FD640BQ39038658-97ACA740-4287-4D96-8158-1866B7542A12Q39139601-E025C36B-1A24-49DD-B1E1-4A9FABE1C43FQ40136119-1C6B1520-4612-4F8D-9211-AFA04607308FQ40138610-D157C094-515D-4B78-B229-292134361C49Q40587576-A0981640-89B9-40B3-B4B5-033C4E7B35E5Q41682772-7113DEF2-0C3F-40BC-AC08-85BAF7F22DA0Q41845465-0757BA8C-EE52-4606-B368-7D031877B711Q41907887-208DBC65-BF13-4493-B19A-2143A9CF2CF1Q42766350-8265B4FE-9463-459D-936F-A5890C22843FQ43637410-9CBC20F0-1603-49FD-865B-2A1B476E842CQ49968014-4BD97770-86F8-4BF8-B838-31BC750B312AQ54259397-730E4DC2-7AF4-498C-9368-A16A01111CD6Q59136481-9F9C7354-DFF9-42FB-8B8B-8FAC3D53B9E5
P2860
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
description
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/01/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/01/01)
@nl
наукова стаття, опублікована в січні 2006
@uk
مقالة علمية (نشرت عام 2006)
@ar
name
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@ast
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@en
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@nl
type
label
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@ast
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@en
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@nl
prefLabel
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@ast
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@en
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@nl
P2860
P921
P3181
P1476
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis
@en
P2093
Sabine Ehrt
Shuangping Shi
P2860
P3181
P356
10.1128/IAI.74.1.56-63.2006
P407
P577
2006-01-01T00:00:00Z